Flashcard cards about each approved vaccine
Last updated on 09/05/2021 - Translations can be found here
Context
More and more vaccines against COVID-19 are getting approved around the world. We have a wealth of data about these vaccines but it can be complex and confusing for the general public. Vaccines rely on different technologies to boost the immune system against the virus responsible for COVID-19 (called SARS-CoV2). Each manufacturer completed their own clinical trials to estimate the efficacy of their vaccines. I wanted to create an easy way for myself and people to reference and compare the different vaccines. The main caveat is that you cannot compare efficacy between vaccines since each clinical trial has its own standard ('end-point') to asses COVID-19 cases.
Design
I aimed to create one very simple flashcard per vaccine taking inspiration from trading cards. Each vaccine card should have a quick reminder of the technology used and metrics about the vaccine. I wanted to colour-code each card and data for easy comparison across the stack.
Early version
I already had made summaries about the science behind each technology so I didn’t explore many sketches. It was more about organising the information than exploring colours and visuals…
Final (almost) version
Some of the data has not been published yet so the cards are not finalised and will be updated in the future. The design is however final and features 8 cards. Each vaccine technology has its own colour. The final design is tailored for smartphone screens to promote accessibility as much as possible.
Free Download and Translations
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. You are free to copy and redistribute the material in any medium or format under the following terms:
- You must give appropriate credit, provide a link to the license, and indicate if changes were made. (basically tag me when you post them please!)
- You may not use the material for commercial purposes.
- If you remix, transform, or build upon the material, you may not distribute the modified material. (Basically, don’t modify the cards please)
Two versions are available in english listing efficacies vs disease severity or vs variants. Only the cards with the efficacy against variants are available in multiple languages. Please note that these were translated over few months ago now so the data will/could be a bit outdated (sorry!)
English ‘V3’
last updated in Sept 2021
Download the cards as .pdf
Old and non-updated vaccine vaccine cards
English ‘V2’
last updated in May 2021
Download the cards as .zip
Download the cards as .pdf
English ‘V1’
last updated in March 2021
Download the cards as .zip
French - Français ‘V1’ translated by LaPipette!
last updated in March 2021
Download the cards as .zip
Simplified Chinese - 简体中文 ‘V1’ translated by Chenlu Yu
last updated in March 2021
Download the cards as .zip
Traditional Chinese - 繁體中文 ‘V1’ translated by Irene Yeung and Hau Kwan Abby Lo
last updated in March 2021
Download the cards as .zip
Traditional Chinese (Cantonese) - 繁體中文(廣東話) ‘V1’ translated by Hau Kwan Abby Lo and Irene Yeung
last updated in March 2021
Download the cards as .zip
Spanish - Español ‘V1’ translated by BioPosts
last updated in March 2021
Download the cards as .zip
Portuguese - Português (Brasil) ‘V1’ translated by Julio Cesar Lorenzi
last updated in March 2021
Download the cards as .zip
Italian - Italiano ‘V1’ translated by Renzo Toffolo
last updated in March 2021
Download the cards as .zip
Slovak - Slovensky ‘V1’ translated by Patrícia Hrašnová
last updated in March 2021
Download the cards as .zip
Serbian - Srpski ‘V1’ translated by Ivana Prokić from Ujedinjeni Protiv Kovida
last updated in March 2021
Download the cards as .zip
Serbian - Српски ‘V1’ translated by Miloš Vasić
last updated in March 2021
Download the cards as .zip
Czech - čeština ‘V1’ translated by Julius Luke
last updated in March 2021
Download the cards as .zip
Romanian - Română ‘V1’ translated by Razvan Nastasa
last updated in March 2021
Download the cards as .zip
Indonesian - Bahasa Indonesia ‘V1’ translated by Adien Esti
last updated in March 2021
Download the cards as .zip
Vietnamese - Tiếng Việt ‘V1’ translated by Ly Nguyen
Download the cards as .zip
Finnish - Suomalainen ‘V1’ translated by Jani Räty
last updated in March 2021
Download the cards as .zip
Georgian - ქართული ‘V1’ translated by Giorgi Chkheidze
last updated in March 2021
Download the cards as .zip
Korean - 한국어 ‘V1’ translated by Jisu Im
last updated in March 2021
Download the cards as .zip
Russian - русский ‘V1’ translated by Kristina Sagaliec
last updated in March 2021
Download the cards as .zip
German - Deutsch ‘V1’ translated by Doğan Doruk Demircioğlu
last updated in March 2021
Download the cards as .zip
Japanese - 日本語 ‘V1’ translated by Yo Nakahara
last updated in March 2021
Download the cards as .zip
Hungarian - Magyar ‘V1’ translated by Attila Imre
last updated in March 2021
Download the cards as .zip
Dutch - Nederlands ‘V1’ translated by Iris Iemenschot
last updated in March 2021
Download the cards as .zip
Bosnian - Bosanski ‘V1’ translated by Zerina Kurtovic
last updated in March 2021
Download the cards as .zip
Albanian - Shqiptare ‘V1’ translated by Orion JUCJA
last updated in March 2021
Download the cards as .zip
Polish - Polskie ‘V1’ translated by Marzena Ciechomska from PSNC as part of the REGIONAL COVID-HUB
last updated in March 2021
Download the cards as .zip
Ukrainian - Український ‘V1’ translated by Anastasiia Filimonova
last updated in March 2021
Download the cards as .zip
Macedonian - Македонски ‘V1’ translated by Dimitar Stevchev
last updated in March 2021
Download the cards as .zip
References
- General reviews:
- Moderna
- BioNTech / Pfizer
- Oxford University/Astrazeneca
- Voysey et. al. 2021 (The Lancet) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- Madhi et. al. 2021 (MedRxiv) Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa
- Voysey et. al. 2021 (The Lancet) Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine
- Johnson & Johson
- Johson & Johson press release (The text doesn’t mention efficacy anymore)
- Phase 1-2a : Sadoff et. al. 2021 (NEJM) Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
- Gamaleya
- Novavax
- Sinopharm
- Sinovac
- Bharat Biotech
Thanks for reading! Let us know what you think!